Drug-eluting stents and bare metal stents in patients with NSTE-ACS: 2-year outcome from the randomised BASKET-PROVE trial

Sune Haahr Pedersen1*, MD, PhD; Matthias Pfisterer2, MD; Christoph Kaiser2, MD, DmSc; Jan Skov Jensen1, MD, PhD, DmSc; Hannes Alber3, MD; Peter Rickenbacher4, MD; Rikke Sørensen1, MD, PhD; Allan Iversen1, MD, PhD; Magnus Thorsten Jensen1, MD; Kim Wadt1, MD; Søren Galatius1, MD, DmSc; for the BASKET-PROVE Investigators